Genetic biomarker may predict cancer patients' response to immunotherapy drug
In a report of a proof-of-principle study of patients with colon and other cancers for whom standard therapies failed, researchers at the Johns Hopkins Kimmel Cancer Center say that mistakes in so-called mismatch repair genes, ...
May 29, 2015
0
111